NCT06451562

Brief Summary

The goal of the surgical correction of scoliosis is to prevent progression of the curve or progression of restrictive lung disease. After scoliosis surgery, patients experience severe pain. The standard treatment for pain relief after scoliosis surgery is the administration of opiates. However, treatment with these substances involves side effects such as respiratory depression, nausea and vomiting, inhibition of bowel activity and itching. To lower the dose of opiates, different types of painkillers and other techniques can be added. The purpose of the study is to compare the effect of instillation of lidocaine (which is an analgesic and anti-inflammatory) or regional anesthesia using Erector spinae plane on the dose of morphine consumption, the intensity of pain, the side effects and the quality of recovery during the first 48 hours after surgery to repair scoliosis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Sep 2024Sep 2026

First Submitted

Initial submission to the registry

May 21, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 11, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

November 12, 2024

Status Verified

November 1, 2024

Enrollment Period

1.8 years

First QC Date

May 21, 2024

Last Update Submit

November 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Morphine consumption

    Dosage of morphine consumption in milligrams that the patients will consume in by pressing on the PCA device in the first 48 hours after surgery to correct scoliosis

    48 hours after surgery

Secondary Outcomes (2)

  • Quality of recovery

    72 hours after surgery

  • Pain intensity,

    48 hours after surgery. The pain will be monitored at 1, 6, 12, 24 and 48 hours after the surgery.

Study Arms (3)

Control

NO INTERVENTION

This group will serve as a control - the patients will receive general anesthesia according to the standard protocol for general anesthesia in this study. Upon the end of the surgery, patients will begin receiving analgesics and anti-nausea treatment according to the standard protocol in this study.

Erector spinae plane block

ACTIVE COMPARATOR

Patients will receive general anesthesia according to the standard protocol for general anesthesia in this study. After induction for anesthesia, before the start of the surgery, the anesthesiologist will perform an ultrasound guided ESP block, according to the ultrasound guided erector spinae plane block protocol

Drug: Lidocaine

Lidocaine

ACTIVE COMPARATOR

Patients will receive general anesthesia according to the standard general anesthesia protocol for this study. In addition, after induction of anesthesia, patients will begin receiving an intravenous infusion of lidocaine at a dose of 0.5 mg per kg per hour, and will continue to receive the infusion after surgery for a total of 24 hours.

Drug: Lidocaine

Interventions

a local anesthetic drug of the amino amide type

Also known as: Lignocaine, Xylocaine
Erector spinae plane blockLidocaine

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients over the age of 12 with normal cognition, who are scheduled to undergo surgery to correct scoliosis and treatment with IV PCA independently for pain relief after surgery; The patients' parents/guardian (in the case of a minor) or the patient himself (in the case of an adult) signed an informed consent form for participation in the study; Patients should be able to operate the PCA device independently

You may not qualify if:

  • Patients who do not agree to participate in the study even if their parents signed an informed consent
  • Patients who are unable to operate the PCA device independently
  • Patients under treatment with opioids or cannabis for chronic pain for more than a month;
  • Drug use of any kind;
  • Alcoholism;
  • Patients with depression, anxiety or post-trauma;
  • Moderate-severe insufficiency of one of the systems - respiratory/cardiac/hepatic/renal;
  • Sensitivity to one of the drugs in the research protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shamir (Asaf Harofe) Medical Center

Be’er Ya‘aqov, 70300, Israel

RECRUITING

MeSH Terms

Conditions

Scoliosis

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Sara Bar Yehuda, PhD

    Shamir (Asaf Harofe) medical center

    STUDY DIRECTOR

Central Study Contacts

Sara Bar Yehuda, PhD

CONTACT

Zoya Haitov Ben Zikri, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Manager of the anesthesia unit

Study Record Dates

First Submitted

May 21, 2024

First Posted

June 11, 2024

Study Start

September 1, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

November 12, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations